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ABSTRACT
Regulatory influence of the G-quadruplex or G4
motif present within the nuclease hypersensitive
element (NHE) in the promoter of c-MYC has been
noted. On the other hand, association of NM23-H2
to the NHE leads to c-MYC activation. Therefore,
NM23-H2 interaction with the G4 motif within
the c-MYC NHE presents an interesting mecha-
nistic possibility. Herein, using luciferase reporter
assay and chromatin immunoprecipitation we
show NM23-H2 mediated c-MYC activation involves
NM23-H2-G4 motif binding within the c-MYC NHE.
G4 motif complex formation with recombinant
NM23-H2 was independently confirmed using fluo-
rescence energy transfer, which also indicated that
the G4 motif was resolved to an unfolded state
within the protein-bound complex. Taken together,
this supports transcriptional role of NM23-H2 via a
G4 motif.
INTRODUCTION
Function of non B-DNA conformations in recombina-
tion, replication and particularly, regulation of gene
expression has been generally appreciated in recent
years, both in prokaryotes (1) and eukaryotes (2,3).
Certain G-rich sequences adopt a particular type of non
B-DNA structure—the G-quadruplex or G4 motif.
G4 motifs are four-stranded planar array of four-
hydrogen bonded guanines (G-quartets) stabilized by
charge coordination with monovalent cations (especially
K
+) resulting from intramolecular or intermolecular
association of DNA strands in parallel or antiparallel
orientation (4,5). These motifs are known to form in
telomere ends of eurkaryotic genomes (6,7), where they
play a central role in telomere extension and are the
focus of targeted anticancer drug development (6,8,9).
Direct in vivo presence of G4 motifs have been observed
only recently within human telomeres (10), in Escherichia
Coli (11) and telomeres of Stylonychia nanochromosomes
(12). In a regulatory context, emerging evidence show sev-
eral important gene promoters like b-globin (13) and reti-
noblastoma susceptibility genes (14), the insulin gene (15),
adenovirus serotype 2 (16), PDGF (17), c-KIT, hypoxia
inducible factor 1-alpha, VEGF, BCL-2 (18), KRAS
(19,20), c-MYB (21) and c-MYC (22,23) harbor G4
motifs with possible functional role. Furthermore, several
recent genome wide studies indicate prevalence of G4
motifs within promoters of human and related species
(24–26) including several bacteria (27). Several inde-
pendent lines of bioinformatics analyses also suggest
genome-wide regulatory function of G4 motifs (27,28).
Repression of c-MYC by G4 motif (using the G4 motif-
binding ligand TMPyP4 (5,10,15,20-tetra(N-methyl-
4-pyridyl) porphine chloride) and over-expression of
c-MYC in case of site-speciﬁc mutation(s) that destabi-
lized the G4 motif within the c-MYC promoter nuclease
hypersensitive element (NHE IIII) indicated functional
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supported by recent ﬁndings demonstrating the func-
tional role of a G4 motif in PDGF-A expression (29).
Formation of G4 motifs in promoter of three muscle-
speciﬁc genes, human sarcomeric mitochondrial creatine
kinase (sMtCK), mouse MCK and alpha7 integrin has
also been noted where the homodimeric form of the tran-
scription factor MyoD associated more eﬃciently with the
tetraplex structural motifs than its target E-box (30,31).
This implicates MyoD in a tetraplex-speciﬁc transcrip-
tional role.
In this context, it is interesting to consider the metas-
tases suppressor protein NM23-H2. Molecular mechanism
of metastases suppression by NM23-H2 is not clear
though for several years now the potent antimetastatic
activity of NM23-H2 stands established (32). NM23-H2,
its close homolog NM23-H1 along with other members
belong to the NM23 family of NDP kinases (33). Earlier
NDP kinases were considered essential housekeeping
enzymes required for maintaining NTP pools. However,
E. coli and yeast were found to be viable without NDP
kinase though certain defects related to DNA repair were
observed in deﬁcient strains (34,35). Interestingly, NM23-
H2 has also been reported to preferentially bind single-
stranded pyrimidine-rich paranemic forms of DNA (36);
the DNA binding and kinase domains appear to have
independent functions though the respective catalytic resi-
dues are housed within the same site (37). Furthermore,
independent studies have demonstrated that: (i) NM23-H2
binds the c-MYC promoter (NHE IIII) and transactivates
c-MYC (38,39) and (ii) the NHE harbors a G4 motif that
suppresses c-MYC expression (22,23).
In view of these we asked whether NM23-H2 binds the
c-MYC promoter G4 motif and the role of this interaction
in c-MYC promoter activation. To address this we ﬁrst
investigated in vivo localization of NM23-H2 on the
c-MYC NHE and studied association of G4 motif with
recombinant NM23-H2. In order to speciﬁcally study
the role of the structural form we used promoter con-
structs devoid of G4 structure formation in presence of
NM23-H2 in cell culture experiments. Finally NM23-H2
mutants were used to address mechanistic issues. Taken
together, results support involvement of the G4 motif
present within the c-MYC promoter as a structural ele-
ment for association of NM23-H2 that confers regulatory
control of c-MYC expression.
METHODS
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed
following the protocol provided by Upstate Biotechnology
with modiﬁcations as in Fast ChIP protocol (40). After
48h of transfection of pcDNA-NM23-H2 or mutants
using Lipofectamine 2000 (Invitrogen), antibody against
overexpressed NM23-H2 (wild-type or H118C, K12A,
H47A mutants) having myc epitope (sigma clone 9 E 10)
was used to immunoprecipitate chromatin in A549 and
HeLa S3 cells. For ChIP in MDA-MB-231 cells, rabbit
polyclonal anti-nm 23-H antibody FL-152: sc-2882 was
used to immunoprecipitate endogenous NM23-H2.
Mouse IgG was used for mock immunoprecipitation in
all the cell lines. Brieﬂy, cells were ﬁxed with 1% formal-
dehyde for 10min and lysed. Chromatin was sheared to an
average size of  1kb using a Misonix 3000 sonicator.
Lysate was precleared using protein-A sepharose beads.
Twenty-ﬁve percent of lysate was used to isolate input
chromatin by phenol–chloroform method and ethanol
precipitation. ChIP was performed overnight at 48C.
Immune complexes were collected using herring sperm
DNA saturated protein-A Sepharose in 3h and washed
extensively. Chelex-100 resin was used to extract DNA
from immunoprecipitated chromatin [as described pre-
viously (40)]. To observe the eﬀects of TMPyP4 on
NM23-H2 mediated c-MYC promoter precipitation,
cells were pretreated with TMPyP4 for 3h before transfec-
tion. The following primer pair was used to amplify a
165-bp region within NHE III1 of c-MYC promoter:
c-MYC_Fwd: CTACGGAGGAGCAGCAGAGAAAG,
c-MYC_Rvs: GTGGGGAGGGTGGGGAAGGT. A
genomic locus from human chromosome 3 was used as
negative control: amplicon position: From 161189123 to
161189415 (+), size of the amplicon: 293, Fwd primer:
TAGGCTGGAGGTCGTGGTTA, Rvs primer: CGGC
GCTTTCGGATTAACT.
Silencing of NM23-H2 using siRNA
Commercially available synthetic siRNA duplex [Santa
Cruz (sc 40774)] against NM23-H2 was used to silence
NM23-H2 in A549 cells. The siRNA duplex [Santa Cruz
(sc 37007] having a scrambled sequence was used as a
negative control; it is known not to bind and degrade
any cellular mRNA. The control siRNA duplex (sc
36869) conjugated with ﬂuorecein was used to monitor
transfection eﬃciency in the cultured cells. Transfection
of siRNA duplexes was done using Lipofectamine 2000
as per manufacturer’s protocol. After 48h of tranfection
of siRNA duplexes, total RNA from A549 cells was iso-
lated using TRI reagent (Sigma) and cDNA synthesized
using cDNA archive kit (Applied Biosystems). Primers
used to probe NM23-H2 and b- actin (as control) tran-
script levels by semi-quantitative real-time (RT)-PCR are
given as Supplementary Data.
Quantitative RT-PCR
Quantitative RT-PCR was performed using ABI 7500 and
SYBR green master mix as per manufacturer’s protocol. A
standard curve for each gene was derived from serial dilu-
tions with an external cDNA. Relative quantiﬁcation for
each of the genes was performed against a house keeping
gene, b2 microglobulin (B2M), according to relative curve
standard method described previously (41). Fold change
was calculated relative to control siRNA treatment.
Primer details are given as Supplementary Data.
Recombinant NM23-H2 expression,
phosphotransferase assay
Recombinant NM23-H2 and mutants (K12A, H118C and
H47A) were expressed in E. coli using the pRSETA-
NM23-H2 clones (see Supplementary Data for plasmid
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obtain His-tagged protein, which was used for all experi-
ments. In an independent preparation His tag was
removed, resin bound protein was cleaved [(0.6mg per
25mg of fusion protein in reaction buﬀer (50mM Tris
pH 8.0, 5mM CaCl2)] and subsequently enterokinase
was removed using enterokinase removal kit. NM23-H2
without His tag gave comparable results as the His-tagged
product in all assays. Phosphotransferase activity of
puriﬁed NM23-H2 was determined as described earlier
(42). One microgram of protein was incubated with
1mM GDP, 10mCi [g-
32P] ATP following initiation with
0.1mM ATP for 10min at room temperature; reaction
stopped with SDS buﬀer, resolved by TLC (Thin Layer
chromatography) and visualized using autoradiography.
Polyacrylamide gelelectrophoresis experiments detectedby
fluorescence energy transfer
The doubly labeled oligonucleotide measuring 0.6mM
[FG27T; 50-F-TGG GGA GGG TGG GGA GGG
TGG GGA AGG-T-30;5 0-ﬂuorescein (F) and
30-TAMRA (T)] was heated at 958C for 10min and then
slowly cooled to room temperature in 10mM HEPES,
2mM MgCl2 and 20mM KCl, pH 7.4 containing 60mM
nonspeciﬁc single strand [poly(dA)] and double-stranded
(ds)DNA [poly(dI.dT)]. Following this 50mg/ml BSA was
added and treated with either recombinant NM23-H2
(6mM), TMPyP4 or both at 378C. NM23-H2 mutants
(K12A, H118C and H47A) were incubated with FG27T
following an identical protocol. FG27T–protein com-
plexes were separated on 5% native polyacrylamide
gel electrophoresis (PAGE) (90min at 70V) in TB buﬀer
and bands visualized by exciting at 473nm and emis-
sion observed at either 520 or 580nm (emission wave-
length of ﬂuorescein and TAMRA, respectively) in
Fujiﬁlm FLA2000 using ImageReader and images pro-
cessed using MultiGauge and LProcess provided by
manufacturer.
Fluorescence energy transfer in solution
Fifty nanomolar of the doubly labeled oligonucleotide
FG27T in 10mM HEPES, pH 7.4 (adjusted with KOH),
20mM KCl, 2mM MgCl2 (for protein activity) was
heated at 978C for 5min and then slowly cooled to
378C. Following this FG27T was incubated (10min at
378C) with increasing concentration of NM23-H2 in
presence of 5.0mM nonspeciﬁc dsDNA [poly(dI.dT)]
and energy transfer was measured by exciting at 473nm.
Emission was observed from 500 to 700nm using a
Fluoromax 3 (Spex) spectroﬂuorimeter. For deter-
mining ﬂuorescence intensity of individual ﬂuorophores,
emission intensities between 522–528nm and 584–590nm
was averaged for donor (ﬂuorescein) and acceptor
(TAMRA; low donor emission was neglected), respec-
tively. To estimate change in energy transfer eﬃciency
the ratio P (=ID/(ID+IA)) was calculated, where ID
and IA are average donor and acceptor intensities,
respectively.
Transfection and luciferase assays
Del-4 plasmid (with 850bp of c-MYC promoter sequence
harboring the two major promoters P1 and P2 in a luci-
ferase reporter cassette; a gift from Bert Vogelstein) alone,
in combination with pcDNA3-NM23-H2 or its mutants
(see Supplementary Data for cloning details) was trans-
fected using Lipofectamine 2000 as per manufacturer’s
protocol in untreated or pretreated (with TMPyP4 or
TMPyP2) HeLa S3 or A549 cells. Cell viability assays
(MTT) indicate that on an average about 93% and 88%
cells are viable after 24 and 48h, respectively, after treat-
ment with 100mM TMPyP4 or TMPyP2. Furthermore, we
also noted that treatment with 100mM TMPyP4 did not
inﬂuence general cell death-related gene expression
changes in genome-wide expression analyses published
recently (43). After 24 or 48h cells were lysed and assayed
using luciferase reporter system from Promega. Variants
of the Del-4 plasmid construct, wherein speciﬁc base sub-
stitutions were incorporated such that G4 motif forma-
tion is unlikely were also employed for luciferase
reporter assays. The G4 motif sequence in Del-4 and the
G4-mutant plasmids (GM1 and GM2) are the following
(substitutions are underlined): Del-4, TGGGGAGGGT
GGGGAGGGTGGGGAAGG; GM1, TGGGGAGGG
TGAGGAGGGTGGGGAAGG; GM2, TGGGGAGG
GTGAAGAGAGTGGGGAAGG. The luciferase activity
was measured using a Berthold Luminometer and counts
normalized using the total protein concentration.
RESULTS
In vivoassociation ofNM23-H2 tothe c-MYC NHE
NM23-H2-mediated transactivation of the c-MYC pro-
moter (reporter assay) via the NHE was noted several
years back (38,39). Though binding of NM23-H2 to the
c-MYC promoter was implicated in these studies it was
not tested directly. We used ChIP to probe physical occu-
pancy of NM23-H2 to c-MYC promoter in diﬀerent
human carcinoma cell lines: lung epithelial carcinoma
(A549), cervical epithelial carcinoma (HeLa S3) and
breast carcinoma (MDA-MB-231). Plasmid construct
pCDNA3-NM23-H2 was used for expression of NM23-
H2 (with Myc-epitope) in HeLa S3 and A549 cells and
ChIP was performed using monoclonal anti-c-MYC anti-
body (from Sigma) or mouse IgG (mock precipitation).
In MDA-MB-231 cells, rabbit polylclonal-nm23-
H-antibody (from Santa Cruz) was used for ChIP to
retrieve DNA sequences bound to endogenous NM23-
H2. PCR ampliﬁcation of c-MYC promoter shows signif-
icant enrichment in immunoprecipitated samples in all
three cell lines compared to mock (IgG) precipitates
(Figure 1a; input represents puriﬁed chromatin used as
positive control). The reason for using anti-c-MYC anti-
body in ChIP experiments (in addition to the polyclonal
nm23-H-antibody used for detecting endogenous
NM23-H2 in MDA-MB-231 cells) was to immunoprecipi-
tate speciﬁcally NM23-H2 bound chromatin fragments
since the polyclonal nm23-H antibody recognizes both
NM23-H2 and NM23-H1 isoforms. Furthermore, it has
174 Nucleic Acids Research, 2009, Vol. 37, No. 1been demonstrated that the anti-c-MYC antibody (clone
9E 10) used by us does not immunoprecipitate endo-
genous c-MYC protein (44). Independently ChIP per-
formed using polyclonal anti-nm23-H in A549 and HeLa
S3 cells also gave similar results. Genomic loci taken as
control showed no relative enrichment in ChIP
(Figure 1a), suggesting enrichment for the c-MYC pro-
moter was speciﬁc.
Physical mapping of NM23-H2 to c-MYC promoter
questions the regulatory aspects of this interaction. We
asked whether perturbing levels of NM23-H2 would
aﬀect c-MYC expression. Small interfering RNA
(siRNA from Santa Cruz) was used to silence NM23-H2
in A549 cells. Silencing was conﬁrmed by semi-quantitative
RT-PCR (Figure 1b) and quantitative RT-PCR
(Figure 1c). Analysis of c-MYC transcript levels by quan-
titative RT-PCR after silencing of NM23-H2 revealed
about 1.8-fold decrease in c-MYC levels (Figure 1d).
NM23-H2 binds G4motif invitro
Prompted by our ﬁndings showing NM23-H2 localization
on the c-MYC NHE we asked whether NM23-H2 binds to
the G4 motif present within the c-MYC NHE. We checked
for complex formation using recombinant NM23-H2 and
the 27-mer oligonucleotide from c-MYC promoter NHE,
which controls c-MYC expression and is known to adopt
G4 motif in vitro (23). Fluorescence resonance energy
transfer (FRET) was used to distinguish between the
folded and unfolded state of the oligonucleotide
(FG27T), labeled with ﬂuorescein (donor) on one end
and TAMRA (acceptor) on the other end, as described
earlier (42). Reaction products were separated by native
PAGE and detected by ﬂuorescence to test whether the
oligonucleotide in complex with protein was folded
or unfolded. Experiments were done in the presence of
100-fold excess of nonspeciﬁc single- and dsDNA to mini-
mize the chances of NM23-H2 binding nonspeciﬁcally. We
observed primarily the folded form in the bound state on
native PAGE (Figure 2a, lane 2). Interestingly, loss in
energy transfer in the protein-bound complex indicated
that the oligonucleotide was unfolded suggesting a G4
motif-resolving function of NM23-H2. Binding of the
ligand TMPyP4 to the c-MYC promoter G4 motif has
been reported earlier (23). We tested the eﬀect of
TMPyP4 on NM23-H2–G4 motif interaction; as expected,
complex formation was inhibited by TMPyP4 (Figure 2a,
lanes 3 and 4). Increase in energy transfer due to folding
of the FG27T was independently observed in PAGE on
increasing K
+ ion concentration however, the eﬀect in
presence of Na
+ was contrasting showing small or no
change in FRET (Supplementary Figure 1).
The inherent kinase activity of NM23-H2 was indepen-
dently conﬁrmed and found to be intact in presence of
TMPyP4 (Figure 2b, lanes 3 and 4). NM23-H2 interaction
with the c-MYC promoter G4 motif was independently
checked using radiolabeled EMSA. Figure 2c, lane 1
shows the reported nuclease activity of the wild-type pro-
tein where protein–DNA complex formation was also
detectable. In presence of TMPyP4, DNA cleavage was
inhibited resulting in increased amount of complex
(Figure 2c, lanes 3 and 4). In order to check whether the
interaction of NM23-H2 was speciﬁc to the G4 motif
formed by the single strand from the c-MYC NHE
vis-a`-vis the NHE duplex we looked at the NM23-
H2-G4 motif interaction in presence of increasing
amount of the complementary strand. This showed that
on formation of duplex DNA the cleavage product
mediated by NM23-H2 decreased indicating preferential
binding of NM23-H2 with the single-stranded form
(Supplementary Figure 2). Independent experiments
were done with the FG27T oligonucleotide using CD
and ﬂuorescence emission in solution to establish loss in
energy transfer once the motif is in the unfolded state
(data not shown). We did not observe signiﬁcant cleavage
of the FRET labeled oligonucleotide in presence of
NM23-H2 within the incubation times used for the
PAGE experiments. Cleavage was observed when the
duration was increased, this may be due to the end label-
ing of the oligonucleotide used for the PAGE experiments.
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Figure 1. NM23-H2 binds c-MYC promoter in vivo (a) ChIP assays
using antibodies against NM23-H2 in multiple cell lines.
Immunoprecipitated DNA samples were PCR ampliﬁed to show
NM23-H2 occupancy of c-MYC promoter and negative control locus.
Primer and locus information are given with ChIP methods; PCR
cycles were maintained in the exponential phase of ampliﬁcation.
(b) Semi-quantitative RT-PCR analysis of NM23-H2 mRNA expres-
sion in A549 cells treated with siRNA duplex against NM23-H2
compared to scrambled (or control) siRNA and untransfected samples.
b-actin mRNA levels remain unchanged. (c and d) Quantitative real-
time PCR analysis. NM23-H2 (c) and c-MYC (d) transcript levels (fold
change is relative to respective transcript levels determined in cells
transfected with control siRNA) in A549 cells treated with NM23-H2
siRNA or control siRNA duplex. Experiments were performed in
triplicate to analyze standard deviations in all cases.
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Figure 2. NM23-H2 binds to G4 motif in vitro.( a) Electrophoretic mobility shift of 27-mer oligonucleotide (FG27T, see Methods) from c-MYC
promoter NHE in presence or absence of NM23-H2 and/or TMPyP4 in 5% native PAGE; protein bands were independently stained by Coomassie
(data not shown). Top panel: schematic representation of energy transfer in unfolded and folded (parallel G4 motif) along with respective pre-
dominant emission wavelengths. (b) Protein function (kinase) activity of NM23-H2 was not aﬀected in presence of TMPyP4. NM23-H2-mediated
phosphorylation of GTP using [g-
32P]ATP was assayed in presence of TMPyP4. Lane 1: [g-
32P]ATP alone; lane 2: with NM23-H2; lanes 3 and 4:
with NM23-H2 and 60mM (lane 3) or 120mM (lane 4) TMPyP4. (c) Nuclease activity of NM23-H2 is inhibited in presence of TMPyP4. Ten-
nanomolar radiolabeled (along with 0.1mM unlabeled) 27-mer oligonucleotide sequence (50-TGG GGAGGGTGGGGAGGGTGG GGAAGG-30)
that forms G4 motif (23) in the c-MYC promoter NHE was incubated with 4.5mM NM23-H2, either alone (lane 2), or with 1mM (lane 3) or 100mM
(lane 4) TMPyP4 in presence of NM23-H2 in buﬀer [10mM HEPES, 2mM MgCl2, 20mM KCl, 50mg/ml BSA, 0.5mM DTT (pH 7.4)]; lane 1:
oligonucleotide only as control. All reactions in (b) and (c) had 60mM single-strand poly(dA) as nonspeciﬁc control and TMPyP4 treatments were for
45min followed by 3h incubation with protein at 378C. (d) FRET (detected in solution) of FG27T (50 nM) as a function of increasing concentration
of NM23-H2 (r=NM23-H2/FG27T) in 20mM K
+; spectra were recorded following a 10-min incubation after each addition. Inset: Change in
energy transfer (represented as P, determined from experimental FRET data) as a function of increasing (r); P=ID/(ID+IA), where ID and IA
are average donor (ﬂuorescein) and acceptor (TAMRA) intensities, respectively. Experiments were done in triplicate and for each value of P error of
  0.07 arbitrary units was observed.
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checked in solution by incubating FG27T with recombi-
nant NM23-H2. FRET of FG27T in presence of NM23-
H2 was detected in solution by monitoring change in
donor emission intensity relative to total donor and accep-
tor emission, which was expressed as the ratio P (see
‘Methods’ section). Increase in P as a function of increas-
ing NM23-H2/FG27T (r, Figure 2d) indicated decrease in
energy transfer, supporting unfolding of the G4 motif
in presence of NM23-H2. Conversely, as expected,
increasing K
+ ion concentration decreased P demonstrat-
ing the eﬀect of K
+ in stabilizing the folded G4 motif
(Supplementary Figure 3). Taken together, this supports
binding and also unfolding of the c-MYC promoter G4
motif by NM23-H2. In Figure 2d we noted that loss in
energy transfer of the folded G4 motif was not complete
[as expected from a fully open FG27T at r=8; for refer-
ence see FRET of FG27T after melting (Supplementary
Figure 4)] indicating only partial opening of the G4 motif
in the protein-bound complex. An alternative explanation
could be that the 50 and 30 ends of FG27T are in close
proximity after unfolding and/or cleavage.
NM23-H2 interaction with c-MYC promoter G4motif
inducesc-MYC expression
Using a luciferase reporter construct harboring the
c-MYC promoter (Del-4) we ﬁrst conﬁrmed (under our
experimental conditions) transactivation of the c-MYC
promoter when transfected with NM23-H2 in HeLa S3
and A549 cells (Figure 3a). As noted before in A31
murine cells (39) increased c-MYC promoter activity was
found in presence of NM23-H2 in both HeLa S3 and
A549 cells (Figure 3a). Next, we asked whether formation
of the reported G4 motif within the c-MYC promoter
(NHE) had any role in NM23-H2-mediated promoter
activity. To test this we used Del-4 based reporter
constructs [G4-mutants 1 and 2 (GM1 and GM2); see
‘Methods’ section] that are unlikely to adopt the G4
motif. In an earlier study it was demonstrated that
the GM1 construct harboring a single G to A substitution
that destabilizes the G4 motif gives  3-fold over-
expression of the c-MYC promoter in contrast to the
repressor-like activity observed otherwise (23). In addi-
tion, we used the second plasmid construct GM2,
where two G-repeats within the sequence were disrupted
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Figure 3. G4 motif is required for NM23-H2-mediated transactivation
of c-MYC.( a) NM23-H2-mediated transactivation of c-MYC is inhib-
ited in presence of TMPyP4, but not TMPyP2. Cells were transfected
with Del-4 (reporter plasmid with c-MYC promoter) and treated with
TMPyP4, TMPyP2, NM23-H2 expressing pCDNA3 plasmid or in com-
bination as indicated (TMPyP4/TMPyP2 treatment was for 3h, prior
to transfection). Luciferase activity is after 48h, normalized to Del-4
transfected untreated cells (not treated with TMPyP4/TMPyP2).
(b) Disruption of G4 motif leads to decreased transactivation. NM23-
H2-induced promoter activity of the reporter construct Del-4 and
G4-mutant constructs (where speciﬁc substitutions that destabilize G4
motif formation were introduced within Del-4); luciferase activity is
relative to NM23-H2 untransfected cells in each case. (c) Loss in trans-
activation in presence of TMPyP4, normalized to cells treated with
same concentration of TMPyP4 but without NM23-H2. (d) ChIP
with NM23-H2-speciﬁc antibody is aﬀected in presence of TMPyP4
but not TMPyP2. Dose-dependent ChIP signal of the 165-bp c-MYC
promoter NHE harboring the G4 motif sequence in HeLa S3 cells when
treated with TMPyP4 or TMPyP2. IgG: ChIP using mouse IgG as
nonspeciﬁc negative control.
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conﬁrmed by CD, data not shown). As expected GM2
had  2.5-fold higher promoter activity compared to
Del-4 (Supplementary Figure 5). Luciferase activity was
measured for Del-4, GM1 and GM2 in presence and
absence of NM23-H2. NM23-H2-mediated transactiva-
tion in case of GM1 and GM2 mutants were only
 30% and 40%, respectively, of that noted for Del-4
(compared to untransfected control in each case;
Figure 3b). Though it is diﬃcult to rule out the possibility
that inﬂuence of NM23-H2 is limited when the back-
ground reporter activity is inherently high (2- to 3-fold
in case of the G4 mutants), taken together with other
observations reported here these results support the role
of NM23-H2-G4 motif interaction in the transactivation
process.
Role of NM23-H2-G4 motif interaction in transcription
of c-MYC was also tested using a second approach—by
using a G4 motif-binding ligand. Suppression of c-MYC
promoter activity in the presence of TMPyP4 has been
observed before (23). We independently observed this in
HeLa S3 and A549 cells where increasing amount of
TMPyP4 led to decreased promoter activity (Figure 3a).
Having established the independent eﬀect of TMPyP4, we
checked for NM23-H2-mediated transactivation in the
presence of TMPyP4 with the reasoning that TMPyP4
binding to the folded G4 motif may inhibit interaction
with NM23-H2. On the other hand, if the transactivation
mechanism does not involve the G4 motif then eﬀect of
TMPyP4 is unlikely. Decrease in the transactivation
potential of NM23-H2 with increasing TMPyP4 concen-
tration was clearly observed in both, HeLa S3 and A549
cells at both 24 and 48h after NM23-H2 transfection
(Figure 3a and c). This supports the model of NM23-H2
interacting with G4 motif. Biochemical eﬀects of TMPyP4
that underlie its binding to G4 motif (9,45), like inhibition
of telomerase (46) and resulting biological eﬀects of ana-
phase bridge formation and in vivo antitumor activity (47)
are reasonably established. These eﬀects were observed to
be prominent with TMPyP4 and not its positional-isomer
TMPyP2, which was deﬁcient in binding to G4 motif but
not dsDNA (23). Therefore, to further validate the speci-
ﬁcity of above results observed in presence of TMPyP4,
we used TMPyP2 as a negative control. We ﬁrst observed
that TMPyP2, in contrast to TMPyP4, had limited eﬀect
on suppression of c-MYC promoter activity in A549 cells
in absence of NM23-H2 (Figure 3a). This was consistent
with previous experiments demonstrating speciﬁc eﬀect
of TMPyP4 and not TMPyP2 in G4-motif-mediated sup-
pression of c-MYC expression (48). In the presence of
NM23-H2, we noted with interest that eﬀect of TMPyP2
on c-MYC transactivation was marginal relative to that
observed for TMPyP4 (Figure 3a). Taken together,
these observations support a regulatory model suggesting
binding of NM23-H2 speciﬁcally to the G4 motif
intracellularly.
In this context, we further reasoned that G4 motif bind-
ing of NM23-H2 may be impeded by TMPyP4 in vivo and
tested ChIP signal in presence of increasing TMPyP4.
Diminished ChIP signals indicating decreased NM23-H2
occupancy of the c-MYC NHE in the presence of
TMPyP4 (Figure 3d) was in line with this hypothesis,
lending support to the transcriptional activation model
that involves G4 motif binding of NM23-H2. Inhibition
of NM23-H2-G4 motif interaction by TMPyP4 is interest-
ing considering that TMPyP4-mediated stabilization of
the G4 motif could, in eﬀect, present a well-formed G4
structure for more eﬃcient NM23-H2 binding. However,
based on inhibition of NM23-H2-induced activation of
c-MYC in presence of TMPyP4, it appears more likely
that TMPyP4 distorts the G4 motif and/or occupies
the binding site required for NM23-H2 binding.
We used TMPyP2 as a negative control and observed
that NM23-H2-ChIP was not dependent on TMPyP2
(Figure 3d). This supported speciﬁc G4 motif binding of
TMPyP4 in vivo and also indicated that non-speciﬁc bind-
ing of TMPyP4 to dsDNA was unlikely. As a second
control we used ChIP with NFkB (p65) antibody. ChIP,
in this case, was not dependent on TMPyP4 (data not
shown) indicating that nonspeciﬁc binding of TMPyP4
to dsDNA was unlikely.
NM23-H2 mutants lackingphosphotransferase or nuclease
function retain c-MYC transactivation
In addition to transcription, NM23-H2 has been attribu-
ted various other functions including suppression
of metastases (49), reactivation of CD 4
+T cells (50)
and regulation of endocytosis of a G-protein-coupled
receptor (51). Taken together, this makes NM23-H2 an
intriguing multifunctional protein where interplay or
‘crosstalk’ between functions is an interesting mechanistic
possibility. In this context, the connection between enzy-
matic phosphotransferase activity and transcription has
been addressed before (52). We explored the interplay
between transcription and endonuclease functions by
expressing the endonuclease mutant NM23-H2
K12A [char-
acterized before (53)] in HeLa S3 cells and checked its
potential to transactivate the c-MYC promoter.
Transactivation of c-MYC promoter by NM23-H2
K12A
was comparable to that of wild-type NM23-H2at both
24 and 48h after transfection (Figure 4a). Next, we
probed NM23-H2
K12A for its ability to bind the G4
motif and observed signiﬁcant loss of FRET in the
DNA-bound complex (Figure 4b, lane 2) indicating a
G4 motif-resolving function like the wild-type protein
(shown in Figure 2a). We further conﬁrmed in vivo occu-
pancy of NM23-H2
K12A on the c-MYC promoter. ChIP
assay in HeLa S3 cells revealed that in vivo c-MYC pro-
moter occupancy by NM23-H2
K12A was similar to that of
NM23-H2
WT (Figure 4c). The mutant NM23-H2
H118C
which lacks phosphotransferase activity is known to
retain its transcription and DNA-binding activity (54).
Likewise, our luciferase results using the Del-4 construct
in HeLa S3 cells also showed c-MYC promoter transacti-
vation that is similar to NM23-H2
WT (Figure 4a). We
further probed the interaction of NM23-H2
H118C interac-
tion with the G4 motif. Figure 4b (lane 3) shows complex
formation of NM23-H2
H118C with the G4 motif was simi-
lar to the wild-type and K12A mutant. This indicated that
a form of NM23-H2 devoid of phosphorylation resolved
the G4 motif like the wild-type factor. In this case also
178 Nucleic Acids Research, 2009, Vol. 37, No. 1ChIP indicated promoter occupancy by NM23-H2
H118C
was similar to that of the wild-type protein (Figure 4c).
Based on these, we conclude that the endonuclease and
phosphotransferase activities of NM23-H2 are indepen-
dent of its transcriptional regulatory activity. NM23-H2
mutants, H118C and K12A have been well characterized
(52,53), we conﬁrmed the reported phosphotransferase
activities under our experimental conditions for both
mutants (Figure 4d). The DNA cleavage activity of the
mutants was also independently conﬁrmed to observe
complete abrogation in case of K12A mutant, while
H118C mutant showed no appreciable change in DNA
cleavage relative to wildtype (data not shown).
Phosphorylated NM23-H2 is deficientin c-MYC
transactivation
We noted that though the un-phosphorylated form
(NM23-H2
H118C) had been studied extensively, role of a
phosphorylated form of NM23-H2 had not been investi-
gated. To test the role of phosphorylated NM23-H2
in transactivation we developed the mutant NM23-
H2
H47A based on the mutant homolog reported from
Mycobacterium tuberculosis, which was deﬁcient in trans-
phosphorylation while autophosphorylation was intact
(55). This results in a phosphorylated protein that is
trapped with phosphate on the histidine-118 residue.
Limited phosphate transfer resulting in relatively lower
amount of GTP in case of human NM23-H2
H47A with
respect to the wild type activity was conﬁrmed
(Figure 4d, lane 3). NM23-H2
H47A was transfected into
HeLa S3 cells to investigate the role of phosphorylated
form in transactivation. Interestingly, NM23-H2
H47A
showed decreased transactivation of the c-MYC promoter
at 24h (Figure 4a), which was not due to decreased in vitro
DNA binding (Figure 4b, lane 4 shows substantial
amount of retarded band) or in vivo promoter occupancy
(ChIP, Figure 4c). Wild-type-like transactivation observed
at 48h (Figure 4a) may be due to slow loss of the protein-
bound phosphate as the recombinant NM23-H2
H47A
showed loss of phosphate with time under in vitro condi-
tions (data not shown). We also noted that the DNA
complex with the phosphorylated form appeared to
show more energy transfer (retarded band is predomi-
nantly green in Figure 4b, lane 4) relative to wild-type
and other mutants. Though further experiments will be
required to understand the role of phosphorylation in
this respect, it is interesting to note that phosphorylated
NM23-H2, in principle, mechanistically connects the enzy-
matic phosphotransferase function of multifunctional
NM23-H2 with its transcriptional role.
DISCUSSION
Results presented here show transactivation of c-MYC
induced by NM23-H2 could be due to binding of
NM23-H2 to the G4 motif within c-MYC promoter.
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Figure 4. Eﬀect of NM23-H2 mutants on c-MYC transactivation. (a and b) Luciferase reporter activity of the Del-4 plasmid on co-transfection with
plasmids expressing NM23-H2 (labeled as H2) and respective mutants in HeLa S3 cells (a); PAGE of complex formation of FG27T with NM23-H2
mutants detected by ﬂuorescence (b) (lanes 1 and 5: FG27T alone; lane 2: K12A; lane 3: H118C; lane 4: H47A); (c) Enrichment of the 165-bp c-MYC
promoter fragment in ChIP with NM23-H2-speciﬁc antibody for NM23-H2 wild-type (WT) and each mutant. (d) Phosphotransferase assay of
mutants showing decreased phosphotransfer relative to WT activity in case of H47A; activities as shown for H118C and K12A mutants were
reported earlier (52,53).
Nucleic Acids Research,2009, Vol. 37,No. 1 179This is supported by in vitro and in vivo (ChIP) interaction
of NM23-H2-G4 motif and decreased transactivation
observed on speciﬁcally destabilizing the G4 motif. In
addition, reduced transactivation and intracellular DNA
binding (ChIP) in presence of TMPyP4, and not TMPyP2,
argues for G4 motif-speciﬁc binding by NM23-H2 as a
plausible mode of c-MYC activation. Though several pro-
teins are known to interact with G4 motifs (56) in vivo
interaction of the G4 motif with a regulatory factor and
the role of this interaction in transcription was not
reported earlier. Recent biochemical results showing bind-
ing of homodimeric MyoD to tetraplex motifs present in
promoter sequences of the muscle-speciﬁc genes alpha7
integrin and sarcomeric Mitochondrial Creatine Kinase
(sMtCK) implicates a similar model in relation to regula-
tion of muscle-speciﬁc genes (57). Selection of NM23-H2
as the putative factor to test G4 motif mediated transcrip-
tion needs mention as NM23-H2 has been attributed with
several diverse functionalities including kinase activity,
promoter-binding and transcription, DNA cleavage and
DNA repair (58). Several previous models have implicated
the possibility of G4 motif binding to NM23-H2, wherein
NM23-H2 binding to paranemic forms of DNA (G4 and
i-motif) present in the c-MYC promoter has been postu-
lated (23,59). This, in addition to the observation that
NM23-H2 binds the c-MYC promoter NHE, and muta-
tions within the NHE alter NM23-H2 mediated regulation
of c-MYC in Burkitt’s Lymphoma (60), make NM23-H2
an interesting ﬁrst candidate in the context of our study
though several other factors (like SP1, CNBP, hnRNP K)
that bind G-rich sequences would be equally interesting
to study.
In order to discern that transcriptional activation was
due to NM23-H2 binding to G4 motif and not dsDNA
several complementary approaches were considered.
First, base substitutions that speciﬁcally disrupt the G4
motif showed much decreased NM23-H2-mediated trans-
activation in two independent cases. Though possible, it is
unlikely that NM23-H2 binding to dsDNA would be sig-
niﬁcantly perturbed due to these substitutions. Second, we
used a G4 motif-binding ligand TMPyP4 as a probe for
the folded motif. Several studies have established intracel-
lular G4 motif-binding of TMPyP4 in telomerase inhibi-
tion and as a repressor of c-MYC (23,61). It was
demonstrated that at 100mM TMPyP4, eﬀect of the
ligand on c-MYC repression was abrogated when speciﬁc
base substitutions that disrupted G4 motif structure were
incorporated within the promoter—any eﬀect due to
dsDNA binding of TMPyP4 is expected to be retained,
particularly at such high concentrations (23). We observed
loss in NM23-H2-induced transactivation of c-MYC in
presence of TMPyP4. This indicated inhibition of
NM23-H2 binding by TMPyP4 suggesting a G4 motif-
NM23-H2 interaction. Third, we employed TMPyP2,
which has signiﬁcantly lower aﬃnity for the G4 motif
compared to TMPyP4; however, both ligands have similar
aﬃnity for dsDNA. Unlike TMPyP4, loss in transactiva-
tion of c-MYC was not evident in presence of TMPyP2.
In addition, ChIP experiments in presence of TMPyP2
showed unperturbed binding of NM23-H2 to the
c-MYC NHE, in contrast to that noted for TMPyP4.
These results argue against dsDNA binding of NM23-
H2 inside cells, which was expected to show similar eﬀects
in presence of both ligands. However, we found that
TMPyP4/TMPyP2 inhibited nuclease activity of NM23-
H2 in a similar fashion in vitro. A possible reason may
be nonspeciﬁc/low aﬃnity binding of TMPyP2 to G4
DNA; an interaction that is expected to be limited inside
cells due to the presence of excess dsDNA. Finally, we
observed speciﬁc NM23-H2-G4 motif binding in vitro,i n
presence of excess non-speciﬁc single strand and dsDNA.
In further support of our ﬁndings, it has been noted by
others that recombinant NM23-H2 binds to single-
stranded but not the double stranded form of the telo-
meric repeat sequence (62).
Together with other observations (including inhibitory
eﬀect of TMPyP4 and not TMPyP2 on NM23-H2-
mediated activation of c-MYC), reduced transactivation
of c-MYC by NM23-H2 on disruption of the G4 motif
presents the G4 motif as a structural element necessary for
NM23-H2-mediated activation of c-MYC. In contrast,
earlier studies (23) and also observations made by us
(for GM2) show that disruption of the promoter G4
motif leads to increased expression of c-MYC, in absence
of NM23-H2. This is supported by TMPyP4-induced sta-
bilization of the G4 motif resulting in reduced promoter
activity, thereby establishing the G4 motif as a suppressor
of c-MYC expression. This makes the contrasting role of
the c-MYC-promoter G4 motif in presence of NM23-H2
evident. Findings reported here support a model implicat-
ing the structural G4 motif (which is a repressor) as a
binding site for NM23-H2. Binding of NM23-H2 may
remove (possibly by unwinding) the G4 motif leading to
c-MYC activation. In Figure 5 we propose a model sum-
marizing above aspects, which builds on the previously
reported ‘repressor-like’ inﬂuence of the G4 motif and
takes into account observations made in this study show-
ing the negative inﬂuence of both, G4 motif-disruption
and TMPyP4-binding, on NM23-H2-mediated activation
of c-MYC expression. Direct interaction of NM23-H2
with the folded G4 motif noted in vitro help in further
validating this regulatory model. It is also possible that
ON
NM23-H2
TMPyP4 
OFF
OFF
Figure 5. Proposed regulatory model for NM23-H2-G4 motif interac-
tion in c-MYC transcription activation. Repressive inﬂuence of the G4
motif (noted earlier) is transformed in to activation of c-MYC expres-
sion on NM23-H2 binding to the G4 motif, which could be due to
removal of the repressor (G4 motif) and/or recruitment of ancillary
transcriptional activators. TMPyP4-binding to the G4 motif inhibits
NM23-H2-G4 motif interaction possibly by disrupting the G4 motif
structure.
180 Nucleic Acids Research, 2009, Vol. 37, No. 1in addition to removal of the G4 motif (repressor) NM23-
H2 binding recruits other ancillary factors for transcrip-
tional activation.
Our observations suggest NM23-H2 as an activator of
c-MYC expression whereby we note decreased levels of
NM23-H2 give lower c-MYC levels. On the other hand,
decreased expression of NM23-H2 has been associated
with enhanced metastatic potential (63,64). In this context,
it is interesting to consider the eﬀect of NM23-H2 on
c-MYC expression. Decreased expression of c-MYC
induces cell cycle arrest and apoptosis in many cell types
including the lung epithelial carcinoma, A549 cells, where
cells appear to halt at G1/S transition and adopt charac-
teristics of apoptosis (65,66). It is also known that activa-
tion of apoptosis signiﬁcantly reduces the outcome of
metastatic spread (67). Therefore, decreased NM23-H2
levels in cancer cells, which in turn would result in reduced
c-MYC expression is expected to decrease apoptosis of
cancer cells endowing them with enhanced metastatic
potential. Our observations are preliminary in this context
and warrant detailed experiments to investigate the role of
NM23-H2 in apoptosis mediated metastases suppression.
In conclusion, based on observations presented herein it
is tempting to speculate the functional role of G4 motifs as
structural recognition elements for NM23-H2 or other
similar factors. Alteration in chromatin leading to forma-
tion/deformation of G4 motifs may lead to transcriptional
regulation thereby directly linking chromosomal structure
to speciﬁc gene regulatory events. Notably, supercoiling-
dependent single-stranded non-B-DNA forms have been
demonstrated to regulate several operons in E. coli (1).
Further support for structure-mediated regulatory control
comes from recent ﬁndings showing formation of non-
B-DNA structures could directly result from supercoiling
induced during transcription where the non-B structural
forms, in turn, recruit structure-speciﬁc regulatory factors
for speciﬁc gene regulatory control (68). Genome-wide
promoter occupancy of NM23-H2 and its role in gene
expression in tandem with other intracellular [several pro-
teins have been implicated as G4 motif-binding (56)] and
extracellular G4 motif-binding molecules (9) will be
required to better understand the regulatory implications
of G4 motifs.
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